"NUMBER NEEDED TO TREAT" ANALYSIS TO ASSESS THE COMPARATIVE OUTCOMES FROM TERIFLUNOMIDE AND DIMETHYL FUMARATE STUDIES IN RELAPSING MULTIPLE SCLEROSIS

被引：0
|
作者：
Leist, T. P. [1 ]
Montalban, X. [2 ]
Miller, A. E. [3 ]
Dive-Pouletty, C. [4 ]
Freedman, M. S. [5 ,6 ]
机构：
[1] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA
[2] Vall dHebron Univ Hosp, Barcelona, Spain
[3] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[4] Genzyme, Chilly Mazarin, France
[5] Univ Ottawa, Ottawa, ON, Canada
[6] Ottawa Hosp Res Inst, Ottawa, ON, Canada
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 03期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND13
引用
收藏
页码：A279 / A280
页数：4
相关论文
共 50 条
  • [31] Dimethyl Fumarate Dose Reduction in Lymphopenic Relapsing Remitting Multiple Sclerosis Patients: Clinical and MRI Outcomes
    Wong, Ka-Ho
    Bacharach, Rae
    Marini, Erica
    Tram Nguyen
    Clardy, Stacey
    Cortez, Melissa
    DeWitt, L.
    Greenlee, John
    Klein, Julia
    Soldan, M. Paz
    Steffens, John
    Rose, John
    NEUROLOGY, 2019, 92 (15)
  • [32] Efficacy of Dimethyl Fumarate in Young Adults with Relapsing-Remitting Multiple Sclerosis: Analysis of the DEFINE, CONFIRM, and ENDORSE Studies
    Lilyana Amezcua
    Yang Mao-Draayer
    Wendy S. Vargas
    Rebecca Farber
    Sara Schaefer
    Filipe Branco
    Sarah M. England
    Nicholas Belviso
    James B. Lewin
    Jason P. Mendoza
    Sai L. Shankar
    Neurology and Therapy, 2023, 12 : 883 - 897
  • [33] Efficacy and safety of first line oral therapies in relapsing-remitting multiple sclerosis: Dimethyl fumarate vs teriflunomide in the Chieti experience
    Di Tommaso, V.
    Mancinelli, L.
    di Ioia, M.
    Farina, D.
    Travaglini, D.
    Pietrolongo, E.
    De Luca, G.
    Lugaresi, A.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 870 - 871
  • [34] Efficacy of Dimethyl Fumarate in Young Adults with Relapsing-Remitting Multiple Sclerosis: Analysis of the DEFINE, CONFIRM, and ENDORSE Studies
    Amezcua, Lilyana
    Mao-Draayer, Yang S.
    Vargas, Wendy
    Farber, Rebecca
    Schaefer, Sara
    Branco, Filipe M.
    England, Sarah
    Belviso, Nicholas B.
    Lewin, James P.
    Mendoza, Jason L.
    Shankar, Sai
    ENDORSE Study Investigators
    NEUROLOGY AND THERAPY, 2023, 12 (03) : 883 - 897
  • [35] COST-EFFECTIVENESS OF FINGOLIMOD, TERIFLUNOMIDE, DIMETHYL FUMARATE AND INTRAMUSCULAR INTERFERON BETA-1A IN RELAPSING-REMITTING MULTIPLE SCLEROSIS
    Zhang, X.
    Hay, J. W.
    VALUE IN HEALTH, 2014, 17 (03) : A59 - A60
  • [36] Efficacy of the Treatments Used in Multiple Sclerosis: From Meta-analysis to Number Needed to Treat
    Garcia-Ruiz, Antonio J.
    Izquierdo-Ayuso, Guillermo
    Navarro-Mascarell, Guillermo
    Montesinos-Galvez, Ana C.
    Martos-Crespo, Francisco
    Jodar-Sanchez, Francisco
    Correa, Manuel
    Garcia-Agua Soler, Nuria
    CLINICAL NEUROPHARMACOLOGY, 2017, 40 (01) : 37 - 42
  • [37] Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience
    D'Amico, Emanuele
    Zanghi, Aurora
    Callari, Graziella
    Borriello, Giovanna
    Gallo, Antonio
    Graziano, Giusi
    Valentino, Paola
    Buccafusca, Maria
    Cottone, Salvatore
    Salemi, Giuseppe
    Ragonese, Paolo
    Bossio, Roberto Bruno
    Docimo, Renato
    Grimaldi, Luigi Maria Edoardo
    Pozzilli, Carlo
    Tedeschi, Gioacchino
    Zappia, Mario
    Patti, Francesco
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2018, 11
  • [38] Dimethyl Fumarate demonstrates Cost-effectiveness vs Teriflunomide in Treatment-naive Patients with Relapsing-remitting Multiple Sclerosis in Sweden
    Hernandez, L.
    Toro-Diaz, H.
    Cele, C.
    Harrington, A.
    Kinter, E.
    Lundqvist, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 138 - 138
  • [39] COST-EFFECTIVENESS ANALYSIS OF DIMETHYL FUMARATE IN THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS IN ITALY
    Mantovani, L. G.
    Furneri, G.
    Cortesi, P. A.
    Puma, E.
    Santoni, L.
    Prosperini, L.
    VALUE IN HEALTH, 2019, 22 : S740 - S741
  • [40] COST-EFFECTIVENESS OF DIMETHYL FUMARATE TREATMENT FOR RELAPSING REMITTING MULTIPLE SCLEROSIS FROM A DANISH PERSPECTIVE
    Olsen, J.
    Wiren, A.
    VALUE IN HEALTH, 2015, 18 (07) : A758 - A758
12345